Skip to main content
. 2021 Dec 13;181:114081. doi: 10.1016/j.addr.2021.114081

Fig. 2.

Fig. 2

NCI R01 nanotechnology-based applications submitted and awarded per fiscal year in the period of 20122020. (A) R01 applications associated with nanotechnology and RNA research (B) R01 applications associated with any nanotechnology and cancer research area. (B). The data were obtained using an internal NIH grant database and contains information on both new and resubmitted grants. Nanotechnology (A) submissions were identified using a search with the NIH RCDC (Research, Condition, and Disease Categorization) term of “nano AND RNA” “nano”, while nanotechnology submissions (B) used search term “nano”.